|
EP1682547A1
|
|
Rsv polymerase inhibitors
|
|
US2004106791A1
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
CA2495744A1
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
MXPA04007705A
|
|
E2 displacement assay for identifying inhibitors of hpv.
|
|
US2003224977A1
|
|
Macrocyclic peptides active against the hepatitis C virus
|
|
CA2474035A1
|
|
Macrocyclic peptides active against the hepatitis c virus
|
|
US2003108862A1
|
|
Direct binding assay for identifying inhibitors of HCV polymerase
|
|
US2003087379A1
|
|
Assay for identifying inhibitors of HIV RT dimerization
|
|
US2003171363A1
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
CN101302182A
|
|
Virus polymerase inhibitors
|
|
CA2448737A1
|
|
Viral polymerase inhibitors
|
|
US2003082769A1
|
|
Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
|
|
CA2383390A1
|
|
Easily removalbe reagents for the mitsunobu reaction
|
|
US6716836B2
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
WO02070739A2
|
|
Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
|
|
EP2335700A1
|
|
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
CA2370396A1
|
|
Hepatitis c inhibitor tri-peptides
|
|
CA2370400A1
|
|
Hepatitis c inhibitor tri-peptides
|
|
CA2369970A1
|
|
Hepatitis c inhibitor tri-peptides
|
|
CA2369711A1
|
|
Macrocyclic peptides active against the hepatitis c virus
|
